Cargando…

Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis

BACKGROUND: There is currently no standard treatment for locoregional recurrence of esophageal squamous cell carcinoma (ESCC) previously treated with radiotherapy. This study aimed to assess the efficacy and safety of re-irradiation for ESCC patients with locoregional recurrence. METHODS: The PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Kuntian, Chen, Jiaohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962014/ https://www.ncbi.nlm.nih.gov/pubmed/35346285 http://dx.doi.org/10.1186/s13014-022-02019-0

Ejemplares similares

Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
por: Zhao, Kaikai, et al.
Publicado: (2020)

Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
por: Takeda, Kazuya, et al.
Publicado: (2021)

Feasibility of carbon‐ion radiotherapy for re‐irradiation of locoregionally recurrent, metastatic, or secondary lung tumors
por: Hayashi, Kazuhiko, et al.
Publicado: (2018)

Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
por: Xu, Xiujuan, et al.
Publicado: (2019)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
por: Liu, Hongjia, et al.
Publicado: (2023)

Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis
por: Hong, Liang, et al.
Publicado: (2018)

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy
por: Kim, Young Suk, et al.
Publicado: (2012)

Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT
por: Xiang, Geng, et al.
Publicado: (2023)

Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma
por: Seyedin, Steven N., et al.
Publicado: (2020)

Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study
por: Sumita, Kiyomi, et al.
Publicado: (2016)

Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer
por: Yang, Wen-Chi, et al.
Publicado: (2020)

A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy
por: Wu, Xun, et al.
Publicado: (2021)

Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinoma
por: Shi, Yu, et al.
Publicado: (2019)

Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection
por: Chung, Seung Yeun, et al.
Publicado: (2019)

Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
por: Jingu, Keiichi, et al.
Publicado: (2017)

Ultra-Hypofractionated Re-Irradiation with Anti-PD-1 Immunotherapy for Locoregionally Recurrent (after Radical Chemo-Radiotherapy) Non-Small Cell Lung Cancer
por: Filippatos, Konstantinos, et al.
Publicado: (2023)

Concurrent radiotherapy and weekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinoma
por: Zhang, Wen-Wen, et al.
Publicado: (2015)

Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer
por: NAKAMURA, RIEKO, et al.
Publicado: (2016)

Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
por: Hu, Jiyi, et al.
Publicado: (2020)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2016)

High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2021)

Rare Direct Locoregional Brain Metastasis and Recurrence in Laryngeal Squamous Cell Carcinoma
por: Ghrewati, Moutaz, et al.
Publicado: (2023)

Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma
por: Ito, Renma, et al.
Publicado: (2022)

Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local Recurrence
por: Touati, Ruben, et al.
Publicado: (2023)

Re-irradiation with stereotactic radiotherapy for recurrent high-grade glial tumors
por: Soykut, Ela Delikgoz, et al.
Publicado: (2023)

Pathological responses to low-dose irradiation and Pepleomycin in Oral squamous cell carcinoma are predictive of Locoregional control
por: Katagiri, Tomohiro, et al.
Publicado: (2020)

Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control
por: Hisano, Osamu, et al.
Publicado: (2018)

The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer
por: Kim, Tae Hyun, et al.
Publicado: (2010)

Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2015)

Efficacy and Safety of Systemic and Locoregional Cisplatin Chronotherapy in Rats with Ovarian Carcinoma
por: Kireeva, Galina, et al.
Publicado: (2021)

Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis
por: Cheng, Yun-jie, et al.
Publicado: (2018)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Tumour associated tissue eosinophilia as a predictor of locoregional recurrence in oral squamous cell carcinoma
por: Rakesh, Nagaraju, et al.
Publicado: (2015)

A rare case of squamous cell carcinoma lung with multiple locoregional recurrences and histological transformation
por: Niwas, Ram, et al.
Publicado: (2018)

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2021)

Outcomes of re-irradiation for oral cavity squamous cell carcinoma
por: Chen, Yen-Chao, et al.
Publicado: (2022)

Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern
por: Bao, Yong, et al.
Publicado: (2013)

Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy: Study protocol for a prospective multi-center phase II trial
por: Li, Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_noemmjgclba0hjko94i4ge93o5